Cingulate Inc. (CING)
NASDAQ: CING · Real-Time Price · USD
4.210
+0.060 (1.45%)
Oct 8, 2025, 11:59 AM EDT - Market open
Cingulate Market Cap
Cingulate has a market cap or net worth of $23.60 million as of October 8, 2025. Its market cap has increased by 110.65% in one year.
Market Cap
23.60M
Enterprise Value
20.95M
1-Year Change
110.65%
Ranking
Category
Stock Price
$4.21
Market Cap Chart
Since the IPO on December 8, 2021, Cingulate's market cap has decreased from $64.29M to $23.60M, a decrease of -63.29%. That is a compound annual growth rate of -23.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 6, 2025 | 22.93M | 40.86% |
| Dec 31, 2024 | 16.28M | 127.09% |
| Dec 29, 2023 | 7.17M | -36.62% |
| Dec 30, 2022 | 11.31M | -63.77% |
| Dec 31, 2021 | 31.21M | -51.44% |
| Dec 8, 2021 | 64.29M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 753.98B |
| Johnson & Johnson | 454.31B |
| AbbVie | 413.22B |
| UnitedHealth Group | 326.22B |
| Novo Nordisk | 264.73B |
| AstraZeneca | 264.35B |
| Novartis AG | 256.18B |
| Abbott Laboratories | 234.25B |